Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and orlistat

vancomycin has been researched along with orlistat in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Baulard, A; Daffé, M; Denis, O; Fontaine, V; Frita, R; Laval, F; Lefèvre, P; Rens, C; Wattiez, R1
Al Kattar, S; Chraibi, S; Fontaine, V; Lambot, C; Menchi, E; Ravon, F; Remmelink, M; Wauthoz, N1

Reviews

1 review(s) available for vancomycin and orlistat

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for vancomycin and orlistat

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Synergism; Fenofibrate; Hypolipidemic Agents; Lactones; Membrane Lipids; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Orlistat; Simvastatin; Vancomycin

2016
In vitro and in vivo local tolerability of a synergistic anti-tuberculosis drug combination intended for pulmonary delivery.
    Journal of applied toxicology : JAT, 2023, Volume: 43, Issue:2

    Topics: Alveolar Epithelial Cells; Animals; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Humans; Lung; Mice; Mycobacterium tuberculosis; Orlistat; Vancomycin

2023